Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryopreserved versus liquid-stored platelets for bleeding after cardiac surgery
ACTRN12612001261808Phase 2Recruiting
- Sponsor
- The University of Queensland
- Start
- Jul 2015
- Modality
- Tissue Cells → Other Cell Types → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of cryopreserved platelets in Bleeding and Thrombocytopenia (2 arms), sponsored by The University of Queensland. Primary endpoints: Protocol feasibility and Acceptability to clinicians compared with conventional platelet transfusion. Started Jul 2015; status: recruiting.
02
Drugs
cryopreserved platelets
03
Conditions
BleedingThrombocytopenia
Beyond the preview
Go deeper on ACTRN12612001261808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612001261808.